China Universal Asset Management Co., Ltd. Axsome Therapeutics, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.05 Billion
- Q1 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 9,782 shares of AXSM stock, worth $986,319. This represents 0.11% of its overall portfolio holdings.
Number of Shares
9,782
Previous 10,276
4.81%
Holding current value
$986,319
Previous $869,000
31.19%
% of portfolio
0.11%
Previous 0.08%
Shares
16 transactions
Others Institutions Holding AXSM
# of Institutions
406Shares Held
36.2MCall Options Held
751KPut Options Held
568K-
Vanguard Group Inc Valley Forge, PA3.88MShares$391 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$333 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.92MShares$295 Million5.58% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$170 Million8.66% of portfolio
-
Macquarie Group LTD Australia, C3976KShares$98.4 Million0.14% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.32B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...